amifampridine has been researched along with Autoimmune Demyelinating Disease, Peripheral in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergin, PS | 1 |
| Miller, DH | 1 |
| Hirsch, NP | 1 |
| Murray, NM | 1 |
1 other study available for amifampridine and Autoimmune Demyelinating Disease, Peripheral
| Article | Year |
|---|---|
Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies.
Topics: 4-Aminopyridine; Amifampridine; Chronic Disease; Demyelinating Diseases; Humans; Neural Conduction; | 1993 |